Can The Netflix Model Eliminate The Most Infectious Disease In America?
Louisiana and Washington want to pay a flat fee to hepatitis C drug makers, such as Gilead, AbbVie and Merck, for unlimited meds each year.
Louisiana and Washington want to pay a flat fee to hepatitis C drug makers, such as Gilead, AbbVie and Merck, for unlimited meds each year.